The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...
Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...
The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.
Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...
Discussing the global healthcare company, Merck & Co., Inc. (NYSE:MRK), Cramer said: “We also hear from two huge drug companies, Merck and Pfizer. Merck, despite some excellent acquisitions, it ...
Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback